Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
1,795 articles
Protein sugar modifications called N-glycans change predictably with age and may serve as reversible biomarkers of biological aging across organ systems.
A meta-analysis of 8 RCTs finds TA-65 modestly elongates telomeres, especially in adults over 60, but doesn't translate to frailty or inflammation benefits.
ALT cancers insert centromeric DNA at telomeres, forming protective chromatin that sustains tumor survival without telomerase.
A comprehensive review covers MNV origins, multimodal imaging diagnosis, and anti-VEGF therapies for macular diseases threatening central vision.
Go beyond the basics and explore the molecular machinery of the Unfolded Protein Response — three distinct signaling branches that determine whether a stressed cell recovers, adapts, or dies.
New cardiology research links DNA methylation clocks to heart failure progression and chewing sugar gum may amplify nitrate vegetable benefits.
A Nature Medicine study finds younger generations are biologically older than their parents at the same age, raising early-onset cancer risk by up to 57%.
A landmark $2.5B AI drug discovery deal targets neuroimmune disorders, potentially cutting development timelines from 4 years to 18 months.
A longevity biotech targets skin aging via TORC1 modulation, raising $20M to commercialize its Re-Q serum backed by serious geroscience.
A completed trial examines how a key inflammation pathway connects periodontitis stages to the chronic low-grade inflammation of aging.
A comprehensive review of how aging reshapes immunity and which vaccine strategies—adjuvants, high-dose, mRNA—best overcome those changes.
Discover how a tiny factory inside your cells can get overwhelmed with age — and why keeping it running smoothly may be one of the most important keys to staying healthy longer.
